Saturday, April 26, 2025
HomeNews

News

Hunter & Bard Joins the Folloze as a Service Technology (FaaST) Agency Program to Optimize ABM-driven Buyer Journeys

Folloze and Hunter & Bard, a leading account-based marketing (ABM) agency, announced a partnership that will bundle the Folloze B2B Buyer Experience Platform with...

Klaviyo Introduces Klaviyo One, a Unified Customer Platform For Large Companies That Need Scale and Speed

Klaviyo, a unified customer platform, announced the development and launch of its new enterprise solution, Klaviyo One, built to help large brands unify all...

Degron Therapeutics Co-Founder Provides New Strategy for Molecular Glue in Tumor Immunotherapy

Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable targets, announced research suggesting lenalidomide, a molecular...

Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding Proposal

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, announced that...

Transgene and BioInvent Announce Positive Progress for BT-001

Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”), a biotech company focused on the discovery...
0FansLike
0FollowersFollow
spot_img

Hot Topics